Dr. Kyung-Mann Kim
MD, PhD
Professor, Haematology
corporate_fareAsan Medical Center, Seoul
Kyung-Mann Kim
MD, PhD
Prof. Kyung-Mann Kim is a Professor of Haematology at Asan Medical Center, one of South Korea's largest and most internationally recognised academic medical centres, affiliated with the University of Ulsan College of Medicine. He specialises in multiple myeloma, Waldenström's macroglobulinaemia, and advanced cellular therapies including CAR-T cell therapy.
With over 20 years of clinical and academic experience in haematological malignancies, Prof. Kim focuses on plasma cell disorders and B-cell lymphoproliferative diseases. His treatment expertise encompasses bortezomib- and lenalidomide-based regimens, autologous stem cell transplantation, and access to CAR-T cell therapy protocols at Asan's specialist haematological cancer and BMT centre. Asan Medical Center is South Korea's largest hospital and a leading destination for patients with complex haematological malignancies seeking specialised care.
CancerFax can coordinate medical report review and consultation support for international patients seeking access to Prof. Kim's expertise, subject to hospital availability and case acceptance.
Why Consider Prof. Kyung-Mann Kim?
Prof. Kim brings together subspecialty expertise in plasma cell disorders and access to advanced cellular therapy programmes at one of Asia's premier haematology centres.
Areas of Specialisation
Plasma cell disorders, lymphoproliferative diseases, and advanced cellular therapies
Prof. Kim's clinical focus covers the full spectrum of plasma cell disorders and selected B-cell malignancies, with a particular emphasis on multiple myeloma and Waldenström's macroglobulinaemia.
Multiple Myeloma
Comprehensive management of newly diagnosed and relapsed/refractory multiple myeloma using proteasome inhibitors, immunomodulatory agents, and cellular therapy.
- arrow_rightBortezomib-based induction and maintenance protocols
- arrow_rightLenalidomide and pomalidomide regimens for eligible patients
- arrow_rightRisk-adapted treatment planning based on cytogenetics and staging
- arrow_rightTransplant eligibility assessment and pre-transplant optimisation
- arrow_rightHigh-dose melphalan conditioning followed by autologous SCT
- arrow_rightPost-transplant maintenance and response monitoring
- arrow_rightReferral and evaluation for CAR-T therapy at Asan's dedicated CAR T-cell Therapy Centre
- arrow_rightAssessment of eligibility for anti-BCMA and other CAR-T constructs
- arrow_rightMultidisciplinary coordination for cellular therapy administration
Waldenström's Macroglobulinaemia & Related Disorders
Specialist management of Waldenström's macroglobulinaemia and related lymphoplasmacytic conditions.
- arrow_rightBTK inhibitor-based and chemoimmunotherapy regimens
- arrow_rightHyperviscosity assessment and plasmapheresis coordination where required
- arrow_rightLong-term monitoring and treatment response evaluation
Procedures & Treatment Approaches
Haematological cancer treatment and cellular therapy services
Prof. Kim's practice encompasses medical management, transplant pathways, and cellular therapy for plasma cell disorders and selected haematological malignancies.
Medical Haematology – Myeloma
Medical OncologySystemic treatment planning and administration for multiple myeloma and related plasma cell disorders.
Autologous Stem Cell Transplantation
TransplantAutologous haematopoietic stem cell transplantation as part of myeloma treatment pathways.
CAR-T Cell Therapy
Targeted TherapyAccess to CAR-T cell therapy for eligible patients with relapsed or refractory haematological malignancies at Asan's dedicated CAR T-cell Therapy Centre.
Second Opinion – Myeloma & Blood Cancers
Second OpinionExpert review of diagnosis, treatment plan, and transplant or cellular therapy eligibility for patients with multiple myeloma and related haematological conditions.
Research & Publications
Clinical research in haematological malignancies
Prof. Kim's academic work is oriented towards improving outcomes in multiple myeloma and related plasma cell disorders through clinical trials, translational research, and evidence-based protocol development.
A detailed publication list and clinical trial participation record may be available on request through CancerFax.
Education & Training
Prof. Kim completed his medical training and doctoral research at the University of Ulsan College of Medicine and undertook additional international training in haematology.
Clinical Experience
Prof. Kyung-Mann Kim is a Professor of Haematology at Asan Medical Center, Seoul, one of South Korea's largest academic medical centres. With over 20 years in haematological oncology, he has built a clinical practice centred on plasma cell disorders and advanced cellular therapies.
Languages & International
Prof. Kim consults in the following languages.
CancerFax can coordinate professional medical interpreter support for international patients consulting with Prof. Kim.
CancerFax can coordinate professional medical interpreter support for international patients where required.
How CancerFax Helps You Access Dr. Kyung-Mann Kim
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Kyung-Mann Kim's team — with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history — prepared as a structured clinical summary for Dr. Kyung-Mann Kim's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Kyung-Mann Kim before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Kyung-Mann Kim's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Kyung-Mann Kim's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Kyung-Mann Kim's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Kyung-Mann Kim
Asan Medical Center actively welcomes international patients and operates a dedicated International Healthcare Centre. CancerFax can coordinate medical report submission and consultation support for patients outside South Korea seeking access to Prof. Kim's expertise, subject to hospital availability and case acceptance.
Prof. Kim specialises in plasma cell disorders and selected B-cell haematological malignancies. His primary focus areas include multiple myeloma, Waldenström's macroglobulinaemia, and lymphoma. He is experienced in both newly diagnosed presentations and relapsed or refractory disease requiring advanced treatment approaches.
Prof. Kim's myeloma treatment practice includes proteasome inhibitor-based regimens such as bortezomib combinations, immunomodulatory agents including lenalidomide and pomalidomide, daratumumab-containing protocols, and autologous stem cell transplantation for eligible patients. He also works within Asan Medical Center's dedicated CAR T-cell Therapy Centre for patients eligible for cellular therapy.
Yes. Asan Medical Center operates a dedicated CAR T-cell Therapy Centre as part of its haematological cancer programme. Eligibility for CAR-T therapy depends on the patient's diagnosis, prior treatment history, disease status, and available constructs. CancerFax can assist with case preparation and submission for eligibility assessment.
A second-opinion request can be submitted through CancerFax with the patient's pathology reports, cytogenetic or molecular results, imaging studies, and prior treatment summary. The CancerFax team will prepare the case for submission and coordinate with the hospital. The final consultation format and availability depend on Prof. Kim's schedule and institutional protocols.
Submit your medical reports and clinical history through CancerFax. The team will review the documents, prepare the case for submission, and coordinate next steps with Asan Medical Center, subject to availability. Asan's International Healthcare Centre also provides direct support for scheduling and logistics for international patients.
Connect with Kyung-Mann Kim Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.